Bio3 Research s.r.l. - Milan Italy   Report issue

For profit Phase 2
Founded: Milan Italy (2001)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2014
NCT02050139
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

l-cysteine (cysteine hydrochloride) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Uremia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1